HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

被引：15

作者：

Iorfida, M. ^{[1
]}

Dellapasqua, S. ^{[1
]}

Bagnardi, V. ^{[2
]}

Cardillo, A. ^{[1
]}

Rotmensz, N. ^{[2
]}

Mastropasqua, M. G. ^{[3
,4
]}

Bottiglieri, L. ^{[3
,4
]}

Goldhirsch, A.

Viale, G. ^{[3
,4
]}

Colleoni, M. ^{[1
]}

机构：

[1] European Inst Oncol, Dept Med, Res Unit Med Senol, Milan, Italy

[2] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy

[3] European Inst Oncol, Div Pathol, Milan, Italy

[4] Univ Milan, Sch Med, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷 / 05期

关键词：

AMPLIFICATION; GENE;

D O I：

10.1093/annonc/mds064

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1371 / 1372

页数：2

共 4 条

[1]

THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY [J].

AKIYAMA, T ;

SUDO, C ;

OGAWARA, H ;

TOYOSHIMA, K ;

YAMAMOTO, T .

SCIENCE, 1986, 232 (4758) :1644-1646

[2]

Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab [J].

Dybdal, N ;

Leiberman, G ;

Anderson, S ;

McCune, B ;

Bajamonde, A ;

Cohen, RL ;

Mass, RD ;

Sanders, C ;

Press, MF .

BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (01) :3-11

[3]

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system [J].

Jacobs, TW ;

Gown, AM ;

Yaziji, H ;

Barnes, MJ ;

Schnitt, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1983-1987

[4]

HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].

SLAMON, DJ ;

CLARK, GM ;

WONG, SG ;

LEVIN, WJ ;

ULLRICH, A ;

MCGUIRE, WL .

SCIENCE, 1987, 235 (4785) :177-182

← 1 →